Fiche centre
Vall d'Hebron University Hospital
Barcelona — Spain
Essais liés4clinical trials
VilleBarcelonalocalisation
PaysSpainlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05374291
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Left atrial appendage Occlusion | Accident vasculaire cérébral | Non applicable | NCT05976685 | ELAPSE — Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy | RECRUITING |
| Dapagliflozin 10 mg/day (oral) | Maladie rénale chronique | Phase 3 | NCT05374291 | The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD | ACTIVE_NOT_RECRUITING |
| FAST — Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification | Migraine | À vérifier | NCT06674772 | FAST — Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification | RECRUITING |
| CGRP antibody or gepant | Migraine | À vérifier | NCT07159750 | EUREkA — Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine | RECRUITING |